DAGGER

Serial Number 97688353
Registration 7159383
700

Registration Progress

Application Filed
Nov 22, 2022
Under Examination
Apr 4, 2023
Approved for Publication
Feb 7, 2023
Published for Opposition
Feb 7, 2023
Registered
Sep 5, 2023

Trademark Image

DAGGER

Basic Information

Serial Number
97688353
Registration Number
7159383
Filing Date
November 22, 2022
Registration Date
September 5, 2023
Published for Opposition
February 7, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Sep 5, 2023
Registration
Registered
Classes
005

Rights Holder

Allogene Therapeutics, Inc.

03
Address
210 E. Grand Avenue
South San Francisco, CA 94080

Ownership History

Allogene Therapeutics, Inc.

Original Applicant
03
South San Francisco, CA

Allogene Therapeutics, Inc.

Owner at Publication
03
South San Francisco, CA

Allogene Therapeutics, Inc.

Original Registrant
03
South San Francisco, CA

Legal Representation

Attorney
Colleen Ganin

USPTO Deadlines

Next Deadline
1496 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-09-05)
Due Date
September 05, 2029
Grace Period Ends
March 05, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

24 events
Date Code Type Description Documents
Feb 28, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Feb 28, 2025 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Feb 28, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 28, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Sep 5, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Sep 5, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Aug 4, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 4, 2023 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Aug 3, 2023 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Aug 3, 2023 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Aug 3, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
Aug 1, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jul 24, 2023 IUAF S USE AMENDMENT FILED Loading...
Jul 24, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Jul 24, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 24, 2023 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Apr 4, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 7, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 7, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 18, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 5, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 4, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 25, 2022 NWAP I NEW APPLICATION ENTERED Loading...
Nov 25, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, preparations for use in the treatment of cancer and tumors; pharmaceutical and biological preparations for immunotherapy, including T Cell therapy; pharmaceutical and biological preparations for immunotherapy, namely, for use in improving immune evasion, improving cell expansion and potency, and/or reducing rejection by patient immune system
First Use Anywhere: Jun 29, 2023
First Use in Commerce: Jun 29, 2023

Classification

International Classes
005